Phosphorylation of STAT3 correlated with LOF p53 mutation and patient survival time in human pancreatic tumors, and inhibition of this pathway could slow down tumor proliferation and formation of stroma [29]. This evidence concerns the gene STAT3 and pancreatic neoplasm.